Treat the Condition, Not Just the Blur: Lead with Myopia Control

A mother and her daughter talk to an optometrist about eyecare and myopia treatment.

Anything that provides a 2:1 benefit may seem like an obvious choice since the item in question is designed to provide dual benefits within one solution.

Just consider these everyday examples: Energy efficient appliances can lower electric bills while also reducing environmental impact. A standing desk instead of the tried-and-true sit-down version can improve posture while also increasing energy and boosting work performance. 

Of course, a parent’s selection of the best treatment option for their child with myopia involves much more consideration than opting for one of the above. Parents naturally want to know whether there’s a way to address the underlying condition, not just manage its day-to-day effects. 

That’s where MiSight® 1 day* comes in. Unlike single vision contact lenses that only serve to correct a child’s refractive error, MiSight® 1 day is specifically designed to help children see clearly1-3 AND slow their myopia progression: a clear 2:1 benefit.2

On the other hand, treating myopia with single vision contact lenses is akin to putting a bucket under a leaky roof — a temporary fix, but it won’t stop the leak, which can lead to more severe problems down the road. In addition to the dual benefits with myopia control soft contact lenses, here are 5 other key reasons to start the myopia conversation with MiSight® 1 day.

1. Single-Vision CLs Let Myopia Worsen Unchecked

In a 3-year, multi-center, double-masked randomized clinical trial, children who wore MiSight® 1 day contact lenses experienced, on average, 59% less myopia progression compared to children in the control group who wore single vision contact lenses.†2

2.  MiSight® 1 day Represents an Investment in a Child’s Future Eye Health

Since MiSight® 1 day is proven to slow the progression of myopia,2 this can in turn reduce the  risk of high myopia which can lead to eye health complications down the road.4 As science tells us, every diopter matters.5

3. Myopia Control Provides More Predictable Care

MiSight® 1 day makes it more likely that fewer prescription increases are needed over time compared to standard single-vision lenses.‡6 Let parents know that myopia control lenses can help keep their child’s vision from getting worse as they grow.*†§2,7

4.  Prescribing MiSight® 1 day Can Strengthen Parents’ Trust

MiSight® 1 day can position your practice as a community leader in pediatric myopia management. This distinction can help you build trust with families, which in turn, can strengthen the patient-doctor relationship.

5. Help Preserve a Child’s Vision & Differentiate Your Practice

Leading with MiSight® 1 day every time can build a network of referrals from parents, siblings, and other providers. This practice approach can also create a long‑term care pathway, ensuring ongoing follow‑ups and consistent patient engagement.

Are you looking for more reasons to start the myopia conversation with MiSight® 1 day? Be sure to read this easy-to-digest 1-page resource filled with additional insights.

19621
More Blog Posts

Related posts

*Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

†Compared to a single vision 1 day lens over a 3-year period.

‡Fitted at 8-12 years of age at initiation of treatment.

§MiSight® 1 day, designed for myopia control, shows sustained slowing of eye growth over time on average. While eyes are still growing; children fit ages 8-12 and followed for 6-years. n=40.

 

References:

1. Sulley A et al, Wearer experience and subjective responses with dual focus compared to spherical, single vision soft contact lenses in children during a 3-year clinical trial. AAO 2019 Poster Presentation. 

2. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8)556-567.

3. Chamberlain P et al, Further comparison of myopia progression in new and established myopia control treatment (MiSight® 1 day) groups. BCLA paper presentation 2019.

4. Tideman JW et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134:1355-1363.

5. Bullimore MA, Brennan NA. Myopia Control: Why Each Diopter Matters. Optom Vis Sci. 2019 Jun;96(6):463-465. 

6. Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6-year findings. Optom Vis Sci 2020;97(E-abstract): 200038.

7. Chamberlain P, et al. Long-term Effect of Dual-focus Contact Lenses on Myopia Progression in Children: A 6-year Multicenter Clinical Trial. OVS 2022 Mar 1;99(3):204-212.

 

19621 04/26